Abstract:Background: Mastocytosis is characterized by an accumulation of clonal mast cells (MCs) in tissues such as the skin. Skin lesions in mastocytosis may be clinically subtle or heterogeneous, and giving the correct diagnosis can be difficult. Methods: This study compiles personal experiences together with relevant literature, discussing possible obstacles encountered in diagnosing skin involvement in mastocytosis and cutaneous mastocytosis (CM). Results: The nomenclature of the term "CM" is ambiguous. The WHO classification defines CM as mastocytosis solely present in the skin. However, the term is also used as a morphological description, e.g., in maculopapular cutaneous mastocytosis (MPCM). This is often seen in systemic, as well as cutaneous, mastocytosis. Typical CM manifestations (MPCM), including mastocytoma or diffuse cutaneous mastocytosis (DCM), all share a positive Darier's sign, and can thus be clinically recognized. Nevertheless, distinguishing monomorphic versus polymorphic MPCM may be challenging, even for experienced dermatologists. Less typical clinical presentations, such as MPCM with telangiectatic erythemas (formerly called telangiectasia macularis eruptiva perstans), confluent, nodular or xanthelasmoid variants may require a skin biopsy for histopathological confirmation. Because MC numbers in CM have a large overlap to those in healthy and inflamed skin, detailed histopathological criteria to diagnose mastocytosis in MPCM are needed and have been proposed. D816V KIT mutational analysis in tissue is helpful for confirming the diagnosis. Biomarkers allow the prediction of the course of CM into regression or evolution of the disease. Further diagnostic measures should screen for concomitant diseases, such as malignant melanoma, and for systemic involvement. Conclusions: Whereas in typical cases the diagnosis of CM may be uncomplicated, less typical manifestations may require specific investigations for making the diagnosis and predicting its course.

How I diagnose systemic mastocytosis

MASTering systemic mastocytosis: Lessons learned from a large patient cohort

Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group

Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management

Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management

Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management

Treatment of systemic mastocytosis: Novel and emerging therapies

A Rare Case of Aggressive Systemic Mastocytosis Involving the Gastrointestinal System and Review of Literature

Challenges in the Diagnosis of Cutaneous Mastocytosis

Advanced systemic mastocytosis-Revised classification, new drugs and how we treat

Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM

Systemic Mastocytosis: State of the Art

A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosis

Systemic mastocytosis with an associated hematological neoplasm (acute myeloid leukaemia with RUNX1::RUNX1T1 fusion) – A case study

Systemic Mastocytosis Mimicking Blastic Plasmacytoid Dendritic Cell Neoplasm: a Case Report

Management of Advanced Systemic Mastocytosis: Clinical Challenges

Interactions between eosinophils and IL-5Rα-positive mast cells in nonadvanced systemic mastocytosis

Altered B-cell, plasma cell, and antibody immune profiles in blood of patients with systemic mastocytosis

A case of systemic mastocytosis mimicking POEMS syndrome A case report

Systemic Mastocytosis with Recurrent Anaphylactic Shock and Multiple Organ Dysfunction Failure

SOHO State of the Art Update and Next Questions | Current and Emerging Therapies for Systemic Mastocytosis